Events

Innovation for e-Commerce Security and Countering Illicit Transactions

When
JUL ’24
Thu
11

09:00 - 16:30

This was 2 years ago

Location

tbc

Programmes
  • Civil Security

This thematic Workshop of the Community for European Research and Innovation for Security (CERIS) aims at presenting and discussing European research and innovative solutions, as well as further capability needs, relevant for security in fighting illicit trafficking and criminal activities in the flow of goods and services across the external borders of the European Union, including the security of e-commerce, financial transactions, and/or the circumvention of sanctions.

Interested audience include practitioners, especially customs and law enforcement authorities, but also innovators and policy makers on capabilities such as those related to detection of threats in the flow of goods and services, and risk assessment. The Workshop will bring together updates and EU-funded projects of innovative European technologies in this field, from big data analysis to advanced and safe detection technologies that minimise the disruption to trade flows; present experiences and opportunities of collaborative research and innovation in Europe; and discuss how research results can be more efficiently exploited.

For more information, please contact HOME-CERIS@ec.europa.eu and monitor the event website.

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Event calendar

  • ERC

Science communication training for ERC grantees

NOV
Mon
09

The ERC is inviting expressions of interest from current ERC grantees for a one-day science communication training taking place in Brussels. Interested ERC grantees are invited to complete the online expression of interest form. The deadline for applications is 24 August 2026 12 pm CEST. Notification of selected participants (approximately 40) is...

Read more
  • Enhancing EU R&I

VALLEYS info day first open call for applicants strand B & C

NOV
Mon
09

The project VALLEYS aims to strengthen knowledge valorisation in Europe by building a network of knowledge valorisation intermediaries connecting more than 150 organisations from over 25 countries, empowering organisations such as TTOs, incubators, science parks, clusters, and citizen engagement entities to adopt and scale the EU Guiding Principles...

Read more
  • Health
  • EIC

EIC VentureMatch Pitching on Health Biotech

NOV
Tue
10

EIC-backed health biotech companies ready to pitch their innovation to investors can Apply for the EIC VentureMatch Pitching on Health Biotech during BIO-Europe.The investor panel includes: NRW.BANK, LifeArc Ventures, DeepTech & Climate Fonds (DTCF), Apollo Health Ventures, Forbion, Bayern Kapital, M Ventures.Organised under the EIC...

Read more
  • Health

Transforming Health and Care Systems Annual Conference 2026

NOV
Tue
10

This one-day pre-conference is organised by the Transforming Health and Care Systems (THCS) Partnership as part of the European Public Health Conference programme. The conference will focus on how health and care systems can respond to climate, equity and innovation challenges.

Read more

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.